Zurueck zur Suche

Reporte zur Charge U008328

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 3 NJ 2 WA 2 NY 1 WY 1 FL 1

VAERS 2213263

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U008328

mild
Staat
CA
Alter
0,1
Geschlecht
F
Eingang
02.04.2022
Impfdatum
28.03.2022
Beginn
29.03.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Abnormal faeces Haematochezia Rotavirus test positive Stool analysis abnormal

Symptomtext

Patient started to have foul smelling loose stools and abd pain on 3/29/22, the day following her vaccines and noted to have streaks of blood on 3/30/22. Went to ED where had normal exam. Stool studies collected and reported + for Rotavirus. Patient had no sick contact, no travel and is not in daycare. Formula fed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
3/30/2022: Enteric pathogen panel by molecular method. Phone call reported + result for Rotavirus to mother
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
-

VAERS 2213263

PFIZER\WYETH · PNEUMO (PREVNAR13) · Charge U008328

mild
Staat
CA
Alter
0,1
Geschlecht
F
Eingang
02.04.2022
Impfdatum
28.03.2022
Beginn
29.03.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Abnormal faeces Haematochezia Rotavirus test positive Stool analysis abnormal

Symptomtext

Patient started to have foul smelling loose stools and abd pain on 3/29/22, the day following her vaccines and noted to have streaks of blood on 3/30/22. Went to ED where had normal exam. Stool studies collected and reported + for Rotavirus. Patient had no sick contact, no travel and is not in daycare. Formula fed.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
3/30/2022: Enteric pathogen panel by molecular method. Phone call reported + result for Rotavirus to mother
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
-

VAERS 2559056

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U008328

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
13.01.2023
Impfdatum
19.12.2022
Beginn
19.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No adverse event; Patient was given RECOMBIVAX HB and PROQUAd that expired; This spontaneous report was received from a nurse concerning a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant therapies included sterile diluent with lot number W026513 and expiration date 15-APR-2025. On 19-DEC-2022, the patient was vaccinated with expired vaccines including hepatitis b vaccine (recombinant) (thimerosal-free) (RECOMBIVAX HB) lot number U008328 with expiration date 16-DEC-2022 and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) with lot number U019285 and expiration date 15-DEC-2022. The administered vaccines had not experienced temperature excursions prior to the date of administration and no adverse events or product quality complaints were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2552086

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U008328

gering
Staat
WY
Alter
-
Geschlecht
U
Eingang
06.01.2023
Impfdatum
03.01.2023
Beginn
03.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no additional AE's were reported; received a dose of RECOMBIVAX HB after expiry; This spontaneous report was received from a nurse, referring to a patient with unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapy and drug reactions/allergies were not reported. On 03-JAN-2023, the patient was vaccinated with hepatitis B vaccine (recombinant) (RECOMBIVAX HB) (thimerosal free) (0.5 milliliter (ml), lot number U008328 has been verified to be a valid lot number, expiration date was reported as 16-DEC-2022, anatomical location was not provided) intramuscularly for prophylaxis (expired product administered). No additional adverse event (AE) details were provided and no additional AE's were reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2540002

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U008328

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
22.12.2022
Impfdatum
19.12.2022
Beginn
19.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; inadvertently administered an expired dose of RECOMBIVAX HB; This spontaneous report was received from a certified medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant medication were not provided. On 19-DEC-2022, the patient was inadvertently vaccinated with an expired dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) 0.5 milliliter, lot # U008328, expiration date 16-DEC-2022, for prophylaxis (route of administration and anatomical vaccination location were not reported) (Expired product administered). It was confirmed that the vaccine did not experience any temperature excursions. No additional adverse events were reported (No adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2530647

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge u008328

gering
Staat
CA
Alter
0,8
Geschlecht
F
Eingang
13.12.2022
Impfdatum
09.12.2022
Beginn
09.12.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

Patient was given an extra dose of HEP B. Patients mother stated the baby is fine no adverse reactions noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2479161

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U008328

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
15.10.2022
Impfdatum
12.08.2022
Beginn
12.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse event reported; Caller is a pharmacist calling to report that improperly stored doses of RECOMBIVAX HB and VARIVAX were administered to the patient on 12AUG2022. No additional information provided. No additional AE reported. No PQC reported. RECOMBIVAX HB- lot U; This spontaneous report has been received from a pharmacist, concerning a patient of unknown age and gender. The patient{s medical history, concurrent conditions, concomitant medications, previous drug reactions, and allergies were not provided. On 12-AUG-2022, the patient was vaccinated with an improperly stored hepatitis B vaccine (recombinant) thimerosal-free (RECOMBIVAX HB) (lot number U008328 has been verified to be valid; expiration date reported and established as 16-DEC-2022), and varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number U028164 has been verified to be valid; expiration date reported and established as 09-SEP-2023) for prophylaxis (doses, vaccination schemes, routes of administration, and anatomical locations were not provided). The administered dose of hepatitis B vaccine (recombinant) thimerosal-free (RECOMBIVAX HB) was stored at a temperature of 48.79 degrees Fahrenheit (F), during a time frame of 2 hours and 43 minutes (conflicting information also reported as 22.87 F during a time frame of 3 hours and 36 minutes), and for varicella virus vaccine live (Oka/Merck) (VARIVAX) a temperature of 33.13 F was reported during a time frame of 14 hours and 55 minutes. No additional temperature excursion were reported for neither of the vaccines. No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2474321

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U008328

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
11.10.2022
Impfdatum
05.08.2022
Beginn
05.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE reported.; Improperly stored doses of RECOMBIVAX HB and VARIVAX were administered to the patient.; This spontaneous report has been received from a pharmacist referring a patient of unknown age and gender. The patient's concurrent conditions, medical history,drugs reactions or allergies and concomitant medications not reported. On 05-AUG-2022, the patient was vaccinated with improperly stored doses of hepatitis B vaccine (recombinant)thimerosal-free (RECOMBIVAX HB) intramuscular injection, vial, lot number U008328 with expiration date: 16-DEC-2022 and with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous Injection, lot number U028164 with expiration date: 09-SEP-2023, both of them administered for prophylaxis (strengths,doses, frequencies, routes of administration and anatomical sites of application were not provided) (product storage error). The hepatitis B vaccine (recombinant) thimerosal-free (RECOMBIVAX HB) had temperature excursion between 48.79 F for 2 hours and 43 minutes and 22.87 F for 3 hours and 36 minutes. Also, varicella virus vaccine live (oka/merck) (VARIVAX) had temperature excursion between 33.13 F for 14 hours and 55 minutes. It was reported that there were no previous temperature excursions. No additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2364575

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U008328

gering
Staat
WA
Alter
3,0
Geschlecht
F
Eingang
11.07.2022
Impfdatum
11.07.2022
Beginn
11.07.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Underdose Vaccination error

Symptomtext

When administering vaccine to patient's left thigh, the patient pulled their arm away and out of parent's grasp and pushed my (administrator) hand away with the vaccine. The vaccine was not fully administered into patient's thigh and the needle was then bent in the process and dropped to the floor. I immediately covered the patients thigh with a child's bandaid that the patient's mother approved prior. I then left the room to find the provider that was seeing the patient's sister to inform her of the incident and ask her to check the patient. The provider then cleared her and they were free to go home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
none
Allergien
adhesives
Vorherige Impfungen
-

VAERS 2359631

MERCK & CO. INC. · HEP B (RECOMBIVAX HB) · Charge U008328

gering
Staat
WA
Alter
5,0
Geschlecht
M
Eingang
06.07.2022
Impfdatum
06.07.2022
Beginn
06.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hepatitis B

Symptomtext

Patient was given 1st Hepatitis B vaccination on 7/6/2022 Patient currently has Hepatitis B Infections without delta agent without hepatic coma

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hepatitis B
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Hepatitis B infection without delta agent without hepatic coma 7 months ago Dysphagia 4 months ago Hydrocephalus, unspecified type 7 months ago Cerebral ventriculomegaly 7 months ago Klinefelter syndrome 7 months ago Malnutrition 7 months ago Developmental delay 7 months ago Presence of programmable ventriculoperitoneal shunt 7 months ago Adopted person 6 months ago
Andere Medikamente
Isopto Atropine 1% Ophthalmic solution (1 drop in left eye every day)
Allergien
Peaches-Hives
Vorherige Impfungen
-